Cited by 712Venous Thromboembolism Diagnosis and ManagementReproductive Health and ContraceptionBlood Coagulation and Thrombosis Mechanisms

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Hormonal contraception and risk of venous thromboembolism: national follow-up study

Open access

Lidegaard, O., Lokkegaard, E., Svendsen, A. L., Agger, C.·2009·BMJ

DOI 10.1136/bmj.b2890PMC PMC2726928

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVE: To assess the risk of venous thrombosis in current users of different types of hormonal contraception, focusing on regimen, oestrogen dose, type of progestogen, and route of administration. DESIGN: National cohort study. SETTING: Denmark, 1995-2005. PARTICIPANTS: Danish women aged 15-49 with no history of cardiovascular or malignant disease. MAIN OUTCOME MEASURES: Adjusted rate ratios for all first time deep venous thrombosis, portal thrombosis, thrombosis of caval vein, thrombosis of renal vein, unspecified deep vein thrombosis, and pulmonary embolism during the study period. RESULTS: 10.4 million woman years were recorded, 3.3 million woman years in receipt of oral contraceptives. In total, 4213 venous thrombotic events were observed, 2045 in current users of oral contraceptives. The overall absolute risk of venous thrombosis per 10 000 woman years in non-users of oral contraceptives was 3.01 and in current users was 6.29. Compared with non-users of combined oral contraceptives the rate ratio of venous thrombembolism in current users decreased with duration of use (<1 year 4.17, 95% confidence interval 3.73 to 4.66, 1-4 years 2.98, 2.73 to 3.26, and >4 years 2.76, 2.53 to 3.02; P<0.001) and with decreasing dose of oestrogen. Compared with oral contraceptives containing levonorgestrel and with the same dose of oestrogen and length of use, the rate ratio for oral contraceptives with norethisterone was 0.98 (0.71 to 1.37), with norgestimate 1.19 (0.96 to 1.47), with desogestrel 1.82 (1.49 to 2.22), with gestodene 1.86 (1.59 to 2.18), with drospirenone 1.64 (1.27 to 2.10), and with cyproterone 1.88 (1.47 to 2.42). Compared with non-users of oral contraceptives, the rate ratio for venous thromboembolism in users of progestogen only oral contraceptives with levonorgestrel or norethisterone was 0.59 (0.33 to 1.03) or with 75 mug desogestrel was 1.12 (0.36 to 3.49), and for hormone releasing intrauterine devices was 0.90 (0.64 to 1.26). CONCLUSION: The risk of venous thrombosis in current users of combined oral contraceptives decreases with duration of use and decreasing oestrogen dose. For the same dose of oestrogen and the same length of use, oral contraceptives with desogestrel, gestodene, or drospirenone were associated with a significantly higher risk of venous thrombosis than oral contraceptives with levonorgestrel. Progestogen only pills and hormone releasing intrauterine devices were not associated with any increased risk of venous thrombosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1136/bmj.b2890

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen components
Jick, H., Jick, S. S., Myers, M. W., Vasilakis‐Scaramozza, C., & Gurewich, V. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91928-7 · Cited by 721
Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study
Spitzer, W. O., Lewis, M. A., Heinemann, L. A. J., Thorogood, M., & MacRae, K. D. (1996) · BMJ · doi:10.1136/bmj.312.7023.83 · Cited by 590
Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen
Bloemenkamp, K. W. M., Helmerhorst, F. M., Rosendaal, F. R., Vandenbroucke, J. P., & Buller, H. R. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91929-5 · Cited by 576
The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance study on Oral Contraceptives based on 142,475 women-years of observation
Dinger, J. C., Heinemann, L. A. J., & Kühl-Habich, D. (2007) · Contraception · doi:10.1016/j.contraception.2006.12.019 · Cited by 472
Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Poulter, N. R., Cl, C., Farley, T., Meirik, O., & Marmot, M. G. (1995) · PubMed · Cited by 404
Oral contraceptives and venous thromboembolism: a five-year national case-control study☆
Lidegaard, Ø., Edström, B., & Kreiner, S. (2002) · Contraception · doi:10.1016/s0010-7824(01)00307-9 · Cited by 332
Population-based study of risk of venous thromboembolism associated with various oral contraceptives
Farmer, R., Lawrenson, R., Thompson, C., Kennedy, J., & Hambleton, I. R. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07496-x · Cited by 329
Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Farley, T., Meirik, O., Cl, C., Marmot, M. G., & Poulter, N. R. (1995) · PubMed · Cited by 319
Venous thromboembolic disease and combined oral contraceptives: Results of international multicentre case‐control study
(1996) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(96)89711-6 · Cited by 259
Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis
Jick, H. (2000) · BMJ · doi:10.1136/bmj.321.7270.1190 · Cited by 193

Flagged first, then by citations

Show all 29 references

Sorted by citations

Items 501–600 of 712

Medikamentell forskyvning av menstruasjon
Juvkam, K. H., & Gudim, H. B. (2013) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.12.0053 · Cited by 1
A practical guide to contraception. Part 1: Contraceptive pills and vaginal rings
Bateson, D. J., Harvey, C., & McNamee, K. M. (2013) · Cited by 1
Perioperative cardiovascular complications following urogynecological operations
Larsen, M. D., Guldberg, R., & Lose, G. (2018) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13457 · Cited by 1
Pulmonary embolism associated with oral contraceptive use – Case report
Witczak, A., Mosiewicz, J., & Prystupa, A. (2015) · Journal of Pre-Clinical and Clinical Research · doi:10.26444/jpccr/71482 · Cited by 1
Pleurisy and pulmonary embolism: physician sees through patient eyes
Cochrane, B. (2020) · Internal Medicine Journal · doi:10.1111/imj.14802 · Cited by 1
Cardiac Arrest in an Adolescent with Pulmonary Embolism
Myers, M., & Devlin, C. (2021) · Journal of Education and Teaching in Emergency Medicine · doi:10.5070/m56455105 · Cited by 1
Changes in some hemostatic variables during oral contraceptive use in young women; a pilot study
Jastrzebska, M. M., Wajda, P., Chełstowski, K., Byra, E., & Sowińska‍-Przepiera, E. (2015) · Diagnostyka Laboratoryjna · doi:10.5604/01.3001.0004.1225 · Cited by 1
How Would You Treat This Patient With Pulmonary Embolism?
Kanjee, Z., Freed, J. A., Carroll, B., & Reynolds, E. E. (2022) · Annals of Internal Medicine · doi:10.7326/m22-0989 · Cited by 1
Does fetal sex influence the risk of venous thrombosis in pregnancy? A cohort study
Virkus, R. A., Mikkelsen, A. P., Lidegaard, Ø., Torp-Pedersen, C. T., Bergholt, T., Rothman, K. J., & Løkkegaard, E. (2023) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2022.11.024 · Cited by 1
New treatments: Opportunities and challenges
Drysdale, A. T., Poleshuck, E. L., Ramsey, M. H., & Monk, C. E. (2024) · Seminars in Perinatology · doi:10.1016/j.semperi.2024.151941 · Cited by 1
Postpartum hormonal contraceptive use in Denmark during 1997–2021
Larsen, S. V., Mikkelsen, A. P., Madsen, K. B., Liu, X., Munk‐Olsen, T., Frøkjær, V. G., & Lidegaard, Ø. (2025) · Sexual & Reproductive Healthcare · doi:10.1016/j.srhc.2025.101075 · Cited by 1
Effects of a Monophasic Hormonal Contraceptive With Norgestimate+Ethinyl Estradiol on Menstrual Bleeding: Protocol and Design of a Multicenter, Prospective, Open-Label, Noncomparative Study in Italy
Cagnacci, A., Grandi, G., Capobianco, G., Fulghesu, A. M., Morgante, G., Biondelli, V., Piccolo, E., Casolati, E., & Mangrella, M. (2025) · JMIR Research Protocols · doi:10.2196/63683 · Cited by 1
The impact of hormonal intrauterine device use on health-related quality of life in women with a history of venous thromboembolism: a systematic review
Chagas, J., Oliveira, J. A., de Oliveira, E. C. F., Martins, G. B. A., de Oliveira, F. R., Ribeiro, D. D., & Rocha, A. L. L. (2025) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2025.2547063 · Cited by 1
Contraceptive Options for Women with Thrombophilia and Thromboembolic Disease
Salcedo, J., Sridhar, A., & Rizack, T. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1233-9_12 · Cited by 1
Side Effects Of Drugs Essay
Dukes, G. (2011) · Side effects of drugs annual · doi:10.1016/b978-0-444-53741-6.00062-3 · Cited by 1
Archivée: Contraceptifs oraux et risque de thromboembolie veineuse : Mise à jour
Reid, R. L., Leyland, N. A., Wolfman, W., Allaire, C., Awadalla, A., Best, C., Dunn, S., Lemyre, M., Marcoux, V., Ménard, C., et al. (2010) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)34747-8 · Cited by 1
Health issues in oral contraception: risks, side effects and health benefits
Spencer, A. L., & Bonnema, R. A. (2011) · Expert Review of Obstetrics & Gynecology · doi:10.1586/eog.11.49 · Cited by 1
The newer contraceptive pills and venous thromboembolism risk
Foran, T. M. (2014) · The Medical Journal of Australia · doi:10.5694/mja14.00274 · Cited by 1
Pulmonary Embolism and Deep Vein Thrombosis in a Woman Taking Contraceptives and with Unhealthy Life Habit: a Case Report
Zhi, W., & Huang, J. (2013) · Chinese Medical Sciences Journal · doi:10.1016/s1001-9294(13)60022-x · Cited by 1
ORAL CONTRACEPTIVES AND WOMEN'S HEALTH
Castracane, V. D., & Jordan, V. C. (2013) · IMPERIAL COLLEGE PRESS eBooks · doi:10.1142/9781848169586_0003 · Cited by 1
Contraception for Women with Diabetes
Arya, S., & Kupesic, S. P. (2017) · Springer eBooks · doi:10.1007/978-3-319-65518-5_18 · Cited by 1
Hormonal contraception used by adolescents and the risk of tromboembolic disease - topical look - part 2
Havlín, M. (2017) · Pediatrie pro praxi · doi:10.36290/ped.2017.067 · Cited by 1
Place of progestogenic oral contraceptives in gynecological practice
Kuznetsova, I. V. (2019) · Medical alphabet · doi:10.33667/2078-5631-2019-1-1(376)-19-26 · Cited by 1
National survey of confirmed thromboembolism related to female hormones in Japan
Sugiura, K., Kobayashi, T., & Ojima, T. (2020) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14303 · Cited by 1
Möglichkeiten der Kontrazeption bei Übergewicht und Adipositas
El-Hadad, S., Insam, C., Unterhuber, K., Merki‐Feld, G. S., & Leeners, B. (2021) · Gynäkologische Endokrinologie · doi:10.1007/s10304-021-00413-7 · Cited by 1
RELAÇÃO ENTRE TROMBOSE E VACINAS COVID-19 - REVISÃO DA LITERATURA
Persch, G. P., Fernandes, G. H., Bitencourt, C. Á., Ferreira, F. S. B., & Xavier, F. D. (2021) · Brasília Médica · doi:10.5935/2236-5117.2021v58a71 · Cited by 1
Obésité, fertilité féminine et contraception
Dubreuil, S., Ciangura, C., & Bachelot, A. (2021) · Elsevier eBooks · doi:10.1016/b978-2-294-76753-1.00056-4 · Cited by 1
Reproductive health
Talabi, M. B., & Clowse, M. E. B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820583-9.00045-2 · Cited by 1
Progestogens in Contraception
Bitzer, J. (2021) · Springer eBooks · doi:10.1007/978-3-030-52508-8_8 · Cited by 1
Laboratory Testing for the Evaluation of Phenotypic Activated Protein C Resistance
Morimont, L., Donis, N., Bouvy, C., Mullier, F., Dogné, J., & Douxfils, J. (2022) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0042-1757136 · Cited by 1
Combined oral contraceptives and the risk of venous thromboembolism carriers of antithrombin, protein C or S deficiency: Sub-analysis of a prospective cohort study
Tormene, D., Campello, E., Simion, C., Poretto, A., Prandoni, P., & Simioni, P. (2022) · Bleeding Thrombosis and Vascular Biology · doi:10.4081/btvb.2022.42 · Cited by 1
Thromboembolierisiko unter kombinierten hormonellen Kontrazeptiva – aktueller Stand und Verschreibungspraxis
Wunder, D. M. (2023) · Praxis · doi:10.1024/1661-8157/a003990 · Cited by 1
History and Physical Examination in Pulmonary Embolism
Matusov, Y. P., & Tapson, V. F. (2023) · Springer eBooks · doi:10.1007/978-3-030-70904-4_9-1 · Cited by 1
Hormonal Contraception and Menopausal Hormone Therapy: A Reference for Orthopaedic Surgeons
Prado, I. P., Ford, A. C., Moreno, C., Seyler, T. M., Slone, H. S., James, A., & Wittstein, J. R. (2023) · Journal of Women s Sports Medicine · doi:10.53646/961wvz55 · Cited by 1
Contraception for Women with Hematologic Abnormalities
Tocce, K. M., & Davis, S. L. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1233-9_11 · Cited by 1
Obesity and Contraception
Damodaran, S., & Swaminathan, K. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416045-3.00006-6 · Cited by 1
Contraception hormonale
Serfaty, D. (2011) · Elsevier eBooks · doi:10.1016/b978-2-294-70921-0.00006-1 · Cited by 1
Breast Feeding and Contraception
Reifsnider, E. (2011) · Wiley eBooks · doi:10.1002/9781444391183.ch14 · Cited by 1
Intrauterine contraception : use in nulligravid women and safety aspects
Kaislasuo, J. (2015) · Työväentutkimus Vuosikirja · Cited by 1
Prevention and Treatment of Venous and Arterial Thrombosis in Patients with Specific Conditions: Diabetes, Hypercoagulable States, Pregnancy, and Renal Insufficiency
Samama, M. M., Conard, J., & Gerotziafas, G. (2012) · Wiley eBooks · doi:10.1002/9781118410875.ch22 · Cited by 1
VENOUS THROMBOEMBOLISM IN SOUTHERN SWEDEN EPIDEMIOLOGY AND RISK FACTORS
Isma, N. (2012) · Lund University Publications (Lund University) · Cited by 1
Carbamazepine coadministration with an oral contraceptive
Deichmann, S., & Luef, G. J. (2013) · Epilepsia · doi:10.1111/epi.12155 · Cited by 1
Commentary on ‘Combined oral contraceptive pills for treatment of acne’
Tan, J. K. L., & Danby, F. W. (2011) · Evidence-Based Child Health A Cochrane Review Journal · doi:10.1002/ebch.845 · Cited by 1
Oral Contraceptives and the Risk of Cardiovascular Disease
Luo, J., & Margolis, K. L. (2010) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-010-0095-7 · Cited by 1
Contraception œstroprogestative et risque thrombotique : des faits cliniques aux conséquences médiatiques
Levesque, H., & Hanslik, T. (2013) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2013.04.019 · Cited by 1
Hormonale Kontrazeption
Stute, P. (2014) · Gynäkologische Endokrinologie · doi:10.1007/s10304-013-0618-7 · Cited by 1
Reply to letter to the editor: “questions to the LASS study group”
Dinger, J. (2016) · Contraception · doi:10.1016/j.contraception.2016.05.010 · Cited by 1
Oral Contraceptive Pills: Combinations, Dosages and the Rationale behind 50 Years or Oral Hormonal Contraceptive Development
Rabe, T., Goeckenjan, M., Hj, A., Pg, C., Dinger, J. C., Ao, M., Lohr, P. A., Creinin, Sabatini, R., & Strowitzki, T. (2011) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 1
Nomégestrol acétate en contraception et risque thromboembolique veineux
Jamin, C. (2012) · Gynécologie Obstétrique & Fertilité · doi:10.1016/j.gyobfe.2012.03.007
Venous thromboembolism in women : an assessment of hormonal, genetic and other risk factors
Bergendal, A. (2013) · Figshare
Contraception in Malignancies
Anggraeni, T. D. (2016) · Indonesian Journal of Obstetrics and Gynecology · doi:10.32771/inajog.v2i3.401
Contraceção e risco de tromboembolismo venoso: um estudo caso-controlo
Medicina, A. D. 6. A. D. M. I. E., Guimarães, A. C., Costa, P., da Saúde, P. A. I. D. C. D. V. E., Rocha, A., Obstetrícia, A. G. D. G. E., Queirós, F., de Imuno-Hemoterapia, A. G., Barbosa, A. P., de Consultor, E. E. I.-H. C. O. G., et al. (2014) · Revista Portuguesa de Clínica Geral · doi:10.32385/rpmgf.v30i5.11386
Hormonale Kontrazeptiva der zweiten, dritten und vierten Generation
Birkhäuser, M. (2010) · Gynäkologische Endokrinologie · doi:10.1007/s10304-010-0384-8
Venöse Thromboembolien unter kombinierten oralen Kontrazeptiva / aktueller Stand
(2009) · Bulletin des Médecins Suisses · doi:10.4414/saez.2009.14694
« Tout ça pour ça » (C. Lelouch) ou bien encore : « Beaucoup de bruit pour rien » (W. Shakespeare)
Jamin, C. (2013) · Gynécologie Obstétrique & Fertilité · doi:10.1016/j.gyobfe.2013.10.010
P-piller og tromboserisiko
Haugen, T. B. (2009) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.09.1137
35-Year-Old Woman With Recurrent Palpitations
Kadakia, K. C., & Daniels, P. R. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0727
Comprehensive Evaluation of Safyral® 2012
Nelson, A. L. (2012) · Women s Health · doi:10.2217/whe.12.50
Do drospirenone-containing oral contraceptives have a higher risk of VTE?
Ribowsky, J. (2011) · JAAPA · doi:10.1097/01720610-201108000-00011
Review: Contemporary oral contraceptives are associated with venous thromboembolism and stroke
DeLoughery, T. G. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-12-201312170-02011
A novel method for predicting the risk of thrombosis and thromboembolism
Leite, K. C., & Marques, R. H. (2014) · Research on Biomedical Engineering · doi:10.1590/rbeb.2014.016
Consumption of combined oral contraceptives and venous thromboembolism in Zagreb, Croatia
Leppée, M., Čulig, J., & Erić, M. (2010) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625187.2010.526259
Oral contraception: from birth control to pregnancy prevention with noncontraceptive benefits
SHULMAN, L. P., & Kiley, J. W. (2011) · Expert Review of Obstetrics & Gynecology · doi:10.1586/eog.11.42
Los anticonceptivos hormonales orales con levonorgestrel y dosis bajas de estrógeno presentan un menor riesgo de trombosis venosa: resultados del estudio caso-control MEGA
Muñoz, E. B. (2010) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/s1134-2072(10)70141-9
New-generation combined oral contraceptives linked to raised risk of thrombosis
Mearns, B. M. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.169
Drospirenone and VTE
Leppée, M., Erić, M., & Čulig, J. (2010) · Journal of Family Planning and Reproductive Health Care · doi:10.1783/147118910790291127
Tiefe Venenthrombose bei junger Frau mit heterozygoter Faktor-V-Leiden-Mutation
Zotz, R. B., Gerhardt, A., & Sucker, C. (2010) · Gefässchirurgie · doi:10.1007/s00772-010-0796-8
Left ventricular thrombus in a patient with congenitally corrected transposition of the great arteries.
Sobczyk, D., & Nosal, M. (2011) · PubMed
Letter by Rebello et al Regarding Article, “Cryptic Loss of Consciousness in a 36-Year-Old Woman”
Rebello, L. C., Haussen, D. C., & Nogueira, R. G. (2015) · Stroke · doi:10.1161/strokeaha.115.010177
Family Planning: Today and in the Future
HARPER, M. J. K. (2010) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-02062-9_12
Hormontherapie bei Thrombophilie
Tóth, B., Rank, A., Franz, C., & Ludwig, M. Z. (2013) · Der Gynäkologe · doi:10.1007/s00129-012-3072-z
Various vitamin and mineral supplements are observed to increase mortality risk in older women, with the exception of calcium, which decreases risk
Crogan, N. L. (2012) · Evidence-Based Nursing · doi:10.1136/ebnurs-2011-100438
Risk of venous thromboembolism in oral contraceptive users varies according to progestin type
Jick, S. S. (2012) · Evidence-Based Nursing · doi:10.1136/ebnurs-2011-100480
Cardiovascular Risk Biomarkers among Oral and Vaginal Hormonal Contraceptive Users
Brandy, K. R. (2011) · University of Minnesota Digital Conservancy (University of Minnesota)
The Best Prophet of the Future is the Past: Oral Contraception and Novel Components
SHULMAN, L. P. (2014) · Journal of Women s Health · doi:10.1089/jwh.2014.4733
Characterisation of oestrogen-responsive microRNAs regulating coagulation factors
Tian, J. (2015) · Murdoch University Research Portal
Drugs, Prescribed: Drug Product Liability
Cooke, C. (2015) · Encyclopedia of Forensic and Legal Medicine · doi:10.1016/b978-0-12-800034-2.00164-6
CONTRACETIVOS ORAIS E RISCO TROMBÓTICO
Salazar, A. (2014)
The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study
STOCKMAN, J. A. (2011) · Yearbook of Pediatrics · doi:10.1016/s0084-3954(09)79679-4
The Risk of Venous Thromboembolism in Algerian Patients
A, C. N. D. (2014) · Pharmaceutica Analytica Acta · doi:10.4172/2153-2435.1000292
Epidemiologic Research Using Administrative Databases: Garbage In, Garbage Out
Lidegaard, Ø. (2011) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3182097025
Mer blodpropp med nyere p-piller
Hem, E. (2012) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.11.1433
Générations et estroprogestatifs, chronique d’une catastrophe annoncée
Linet, T. (2013) · Vocation Sage-femme · doi:10.1016/j.vsf.2013.05.002
From research to clinical practice: viewpoint on the problem of thrombotic risks in the use of oral and nonoral combined hormonal contraceptives
Татарчук, Т. Ф., Тутченко, Т. Н., & Яроцкая, Н. В. (2014) · Reproductive Endocrinology · doi:10.18370/2309-4117.2014.16.18-25
Quelle contraception pour la femme
Julen, O., & Godinho, A. (2011)
Long-term consequences of pregnancy-related venous thrombosis
Wik, H. S. (2013) · NORA - Norwegian Open Research Archives
With OCs, Hormone Type and Amount Matter for Thrombotic Risk
Biggs, W. S. (2009) · Journal watch · doi:10.1056/wh200909170000004
Thrombotic Risk of Contraceptives and Other Hormonal Therapies
Sood, S. L., & Konkle, B. A. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2296-9.00033-6
Clinical Challenges in Venous Thromboembolism
Mäkelburg, A. B. (2014) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Female physiology meets psychology
Cobey, K. D. (2013)
Risk Factors and the Role of Ultrasound in the Management of Extremity Venous Disease
Polak, J. F., & Pellerito, J. S. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1417-3.00020-6
Accidenti vascolari cerebrali nella donna
Lamy, C. (2016) · EMC - Neurologia · doi:10.1016/s1634-7072(16)80383-9
Severe Mesenteric Venous Thrombosis After Laparoscopic Cholecystectomy
Wolk, S., Plodeck, V., Weitz, J. I., & Distler, M. (2014) · CRSLS Journal of the Society of Laparoscopic and Robotic Surgeons · doi:10.4293/crsls.2014.00371
OVERCOME BARRIERS IN PRESCRIPTION OF HORMONAL CONTRACEPTION (CLINICAL LECTURE)
Pustotina, O. A., & Герейбекова, Э. Р. (2016) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2016-12-56-60
Venous Thromboembolism
Fitzgerald, K. C., & Glynn, R. J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-384978-6.00067-4
Bewertung des Thromboembolierisikos unter hormonalen Kontrazeptiva
Ludwig, M. Z. (2017) · gynäkologie + geburtshilfe · doi:10.1007/s15013-017-1110-6
ARTICLE FROM O&G MAGAZINE AND INVITED COMMENTARY Polycystic Ovarian Syndrome
Ogilvie, M. (2016)
Impact of combined hormonal therapy on coagulation inhibitory proteins
Ibrahimi, E., & Koni, M. (2016) · Eastern Journal Of Medicine · doi:10.5505/ejm.2016.52388
Contraception and menstrual bleeding during venous thromboembolism treatment: Does current practice reflect expert option?
Kevane, B., & Áinle, F. N. (2017) · Thrombosis Research · doi:10.1016/j.thromres.2017.04.013
No 329-Consensus canadien sur la contraception (4e partie de 4) : chapitre 9 – contraception hormonale combinée
Black, A., Guilbert, É., Costescu, D., Dunn, S., Fisher, W. A., Kives, S. L., Mirosh, M., Norman, W. V., Pymar, H. C., Reid, R. L., et al. (2017) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2017.02.003

Authors: Lidegaard, O., Lokkegaard, E., Svendsen, A. L., & Agger, C.
Affiliations: University of Copenhagen (DK)
Venue: BMJ
Publisher: BMJ
Published: 2009-08-13
Volume: 339
Issue: aug13 2
Pages: b2890-b2890
ISSN: 0007-1447 (ISSN-L)
0959-8138
1468-5833
DOI: 10.1136/bmj.b2890
PMC: PMC2726928
OpenAlex: W2027062965
Cited by: 709
References: 29
Citations by year: 2026: 19 · 2025: 39 · 2024: 17 · 2023: 27 · 2022: 35 · 2021: 42 · 2020: 33 · 2019: 31 · 2018: 34 · 2017: 46 · 2016: 32 · 2015: 41 · 2014: 61 · 2013: 74 · 2012: 45
FWCI: 44.51
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc
Locations: BMJ (publishedVersion, cc-by-nc)
Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
PubMed Central (publishedVersion, cc-by-nc)
PubMed (publishedVersion)
Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Funders: Rigshospitalet
Topics: Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Keywords: hormonal contraception, venous thromboembolism, deep vein thrombosis, pulmonary embolism, oral contraceptives, estrogen dose, progestogens, levonorgestrel, norethisterone, desogestrel, gestodene, drospirenone, cyproterone, route of administration, duration of use, thrombosis risk
MeSH terms: Adolescent, Adult, Contraceptives, Oral, Combined, Contraceptives, Oral, Hormonal, Denmark, Epidemiologic Methods, Female, Humans, Middle Aged, Age Distribution, Venous Thromboembolism, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hormonal contraception and risk of venous thromboembolism: national follow-up study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks